Surface expression of collagen receptor Fc receptor-γ/glycoprotein VI is enhanced on platelets in type 2 diabetes and mediates release of CD40 ligand and activation of endothelial cells

Diabetes

Volumn 53, Issue 8, 2004, Pages 2117-2121

  Cabeza, Natalia ^a   Li, Zhongyan ^a   Schulz, Christian ^a   Kremmer, Elisabeth ^b   Massberg, Steffen ^a   Bültmann, Andreas ^a   Gawaz, Meinrad ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND; COLLAGEN; COLLAGEN RECEPTOR; CYTOKINE; FC RECEPTOR; FC RECEPTOR GAMMA; GLYCOPROTEIN VI; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; MONOCYTE CHEMOTACTIC PROTEIN 1; PADGEM PROTEIN; RECEPTOR SUBUNIT; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR;

ARTICLE; ATHEROSCLEROSIS; CELL ACTIVATION; CELL CULTURE; CELL SURFACE; COMPLEX FORMATION; CONTROLLED STUDY; ENDOTHELIUM CELL; HIGH RISK PATIENT; HUMAN; HUMAN CELL; HUMAN UMBILICAL VEIN ENDOTHELIUM CELL; ISCHEMIA; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOSIS; UMBILICAL VEIN;

BLOOD PLATELETS; CD40 LIGAND; CELL ADHESION MOLECULES; CELL LINE; CHEMOKINE CCL2; DIABETES MELLITUS, TYPE 2; ENDOTHELIUM, VASCULAR; FLOW CYTOMETRY; HUMANS; PLATELET MEMBRANE GLYCOPROTEINS; RECEPTORS, COLLAGEN; RECEPTORS, IGG; UMBILICAL VEINS;

EID: 3242780114     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.53.8.2117     Document Type: Article

References (41)

1. Garcia MJ, McNamra PM, Gordon T, Karmel WB: Morbidity and mortality in diabetics in the Framingham population: 16-year follow-up study. Diabetes 23:105-111, 1974
2. Kannel WB, McGee DL: Diabetes and cardiovascular disease: Framingham Study. JAMA 241:2035-2038, 1979
3. Nathan DM: Long-term complications of diabetes mellitus. N Engl J Med 328:1676-1685, 1993
4. Colwell JA, Nesto RW: The platelet in diabetes: focus on prevention of ischemic events. Diabetes Care 26:2181-2188, 2003
5. Carr ME: Diabetes mellitus. A hypercoagulable state. J Diabetes Complications 15:44-54, 2001
6. Colwell JA, Winocour PD, Lopes-Virella MF: Platelet function and platelet-plasma interactions in atherosclerosis and diabetes mellitus. In Ellenberg and Rifkin's Diabetes Mellitus: Theory and Practice. Rifkin H, Porte D, Eds. New York, Elsevier, 1990, p. 249-256
7. Colwell JA: Pharmacological strategies to prevent macrovascular disease in NIDDM. Diabetes 46:131-134, 1997
8. Yamashiro K, Tsujikawa A, Oishida S, Usui T, Kaji Y, Honda Y, Ogura Y, Adamis AP: Platelets accumulate in the diabetic retinal vasculature following endothelial death and suppress blood-retinal barrier breakdown. Am J Pathol 163:253-259, 2003
9. Halushka PV, Rogers RC, Loadholt CB, Colwell JA: Platelet thromboxane synthesis in diabetes mellitus. J Lab Clin Med 97:87-96, 1981
10. Sagel J, Colwell JA, Crook L, Laimins M: Increased platelet aggregation in early diabetes mellitus. Ann Intern Med 82:733-738, 1975
11. Mandal S, Sarode R, Dash S, Dash RJ: Hyperaggregation of platelets detected by whole blood platelet aggregometry in newly diagnosed non insulin-dependent diabetes mellitus. Am J Clin Pathol 100:103-107, 1993
12. Yazbek N, Bapat A, Kleiman N: Platelet abnormalities in diabetic mellitus, Coron Artery Dis 14:365-371, 2003
13. Sobol AB, Watala C: The role of platelets in diabetes-related vascular complications. Diabetes Res Clin Pract 50:1-16, 2000
14. Tschoepe D, Schwippert B, Schettler B, Kisel U, Rothe H, Roesen P, Gries FA: Increased GPIIB/IIIA expression and altered DNA-ploidy pattern in megakaryocytes of diabetic BB-rats. Eur J Clin Invest 22:591-598, 1992
15. Tschoepe D: The activated megakaryocyte-platelet-system in vascular disease, Semin Thromb Hemost 21:152-160, 1995
16. Martina V, Bruno GA, Trucco F, Zumpano E, Taglibue M, Di Bisceglie C, Pescarmona G: Platelet cNOS activity is reduced in patients with IDDM and NIDDM. Thromb Haemost 79:520-522, 1998
17. Osende JI, Badimon JJ, Fuster V, Herson P, Rabito P, Vidhum R, Zaman A, Rodrigez OJ, Lev EI, Rauch U, Heflt G, Fallon JT, Crandall JP: Blood thrombogenicity in type 2 diabetes mellitus patients is associated with glycemic control. J Am Coll Cardiol 38:1307-1312, 2001
18. Calverley DC, Hacker MR, Loda KA, Brass E, Buchanan TA, Tsao-Wei DD, Groshen S: Increased platelet Fc receptor expression as a potential cause of platelet hypersensivity to collagen in diabetes mellitus. Br J Haematol 121:139-142, 2003
19. Calverley DC, Brass E, Hacker MR, Tsao-Wei DD, Espina BM, Pullarkat VA, Hodis HN, Groschen S: Potential role of platelet FcγRIIA in collagen-mediated platelet activation associated with atherothrombosis. Atheroselerosis 164:261-267, 2002
20. Nieswandt B, Watson SP: Platelet-collagen interaction: is GPVI the central receptor? Blood 102:449-461, 2003
21. Alberio L, Dale GL: Platelet-collagen interactions: membrane receptors and intracellular signalling pathways. Eur J Clin Invest 29:1066-1076, 1999
22. Massberg S, Gawaz M, Grüner S, Schulte V, Konrad I, Zohlnhofer D, Heinzmann U, Nieswandt B: A crucial role of glycoprotein VI for platelet recruitment to the injured arterial wall in vivo. J Exp Med 197:41-49, 2003
23. Gawaz M, Ruf A, Neumann FJ, Pogátsa-Murray G, Dickfeld T, Zohlnhöfer D, Schönfig A: Effect of glycoprotein IIb-IIIa receptor antagonism on platelet membrane glycoproteins after coronary stent placement. Thromb Haemost 80:994-1001, 1998
24. Shattil SJ, Cunningham M, Hoxie JA: Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry. Blood 70:307-315, 1987
25. Gawaz M, Neumann FJ, Schömig A: Evaluation of platelet membrane glycoproteins in coronary artery disease: consequences for diagnosis and therapy. Circulation 99:E1-E11, 1999
26. Gawaz M, Neumann FJ, Ott I, Schiessler A, Schömig A: Platelet function in acute myocardial infarction treated with direct angioplasty. Circulation 93:229-237, 1996
27. May AE, Kälsch T, Massberg S, Herouy Y, Schmidt R, Gawaz M: Engagement of glycoprotein IIb/IIIa (α(IIb)β3) on platelets upregulates CD40L and triggers CD40L-dependent matrix degradation by endothelial cells. Circulation 106:2111-2117, 2002
28. Gawaz M, Page S, Massberg S, Nothdurfter C, Weber M, Fischer C, Ungerer M, Brand K: Transient platelet interaction induces MCP-1 production by endothelial cells via I kappa B kinase complex activation. Thromb Haemost 88:307-314, 2002
29. Gawaz M, Neumann FJ, Dickfeld T, Koch W, Laugwitz KL, Adelberger H, Langenbrink K, Page S, Neumeier D, Schömig A, Brand K: Monocyte chemotactic protein-1 secretion and surface expression of intercellular adhesion molecule-1 on endothelial cells. Circulation 98:1164-1171, 1998
30. Henn V, Slupsky JR, Grafe M, Anagnostopoulos I, Foster R, Müller-Berghaus G, Kroczek RA: CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 391:591-594, 1998
31. Massberg S, Brand K, Grüner S, Page S, Muller E, Bermeier W, Richter T, Lorenz M, Konrad I, Nieswandt B, Gawaz M: A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J Exp Med 96:887-896, 2002
32. Winocour PD: Platelet abnormalities in diabetes mellitus. Diabetes 41:26-31, 1992
33. Bern MM: Platelet function in diabetes mellitus. Diabetes 27:342-350, 1978
34. Hendra T, Betteridge DJ: Platelet function, platelet prostanoids and vascular prostacyclin in diabetes mellitus. Prostaglandins Leukot Essent Fatty Acids 35:197-212, 1989
35. Tschoepe D, Driesch E, Schwippert B, Nieuwenhuis HK, Gries FA: Exposure of adhesion molecules on activated platelets in patients with newly diagnosed IDDM is not normalized by near normoglycemia. Diabetes 44:90-94, 1995
36. Colwell JA: Aspirin therapy in diabetes. Diabetes Care 20:1767-1771, 1997
37. L'Esperance FA, James WA, Judson PH: The eye and diabetes mellitus. In Ellenberg and Rifkin's Diabetes MeUitus: Theory and Practice. Rifkin H, Porte D, Eds. New York, Elsevier, 1990, p. 661-683
38. Best D, Senis YA, Javis GE, Eagleton HJ, Roberts DJ, Salto T, Jung SM, Moroi M, Harrison P, Green FR, Watson SP: GPVI levels in platelets: relationship to platelet function at high shear. Blood 102:2811-2818, 2003
39. Schönbeck U, Sukhova GK, Shimizu K, Mach F, Libby P: Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice. Proc Natl Acad Sci U S A 97:7458-7463, 2000
40. Gum PA, Kottke-Marchant K, Welsh PA, White J, Topol EJ: A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease. J Am Coll Cardiol 41:961-965, 2003
41. Müller I, Besta F, Schulz C, Massberg S, Schömig A, Gawaz M: Prevalence of clopidogrel non-responders among patients with stable angina pectoris scheduled for elective coronary stent placement. Thromb Haemost 89:783-787, 2003